Orientations

Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managers

World Health Organization (WHO)

The need to keep vaccines in a 2°C to 8°C cold chain is a constraining factor for many immunization campaigns due to limited storage capacity and/or limited ice pack freezing capacity; supplementary immunization activities planned across sub-Saharan Africa are a good example. In 2012, the license for the Serum Institute of India’s meningitis A vaccine, MenAfriVac™, was changed based on a thorough review of scientific data by regulatory authorities and the World Health Organization (WHO) to allow for the use of the vaccine for a period of up to four days at temperatures of up to 40°C in a controlled temperature chain (CTC). This document provides countries with guidance on when and how to take advantage of this flexibility.

Auteurs

Langues

Année de publication

2013

Type

Orientations

Catégories

  • Vaccins et dispositifs d'administration

Maladies

  • Méningite à méningocoques

Organisations

  • Organisation Mondiale de la Santé (OMS)

Mots-clés

  • Campagne
  • Chaîne de température contrôlée (CTC)
  • MenAfriVac

CTC_PUBLICATIONS

Vous pouvez trouver plus d’informations sur "CTC_PUBLICATIONS" dans les rubriques suivantes :

TitreAuteurAnnéeTypeLangue
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : adaptation guide and facilitators guideWorld Health Organization (WHO)2013GuidanceAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : training module for organizing immunization sessionsWorld Health Organization (WHO)2013TrainingAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managersWorld Health Organization (WHO)2013GuidanceAnglais, Français
Delivering MenAfriVac using the controlled temperature chain approachPATH, World Health Organization (WHO)2013Case studyAnglais, Français
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesisChristopher P. Seaman, Anna-Lea Kahn, Debra Kristensen, Robert Steinglass, Dijana Spasenoska, Nick Scott, Christopher Morgan2022Journal articleAnglais
How to monitor temperatures in the vaccine supply chainUNICEF, World Health Organization (WHO)2015GuidanceAnglais, Français
Guidelines on the stability evaluation of vaccines for use under extended controlled temperature conditions, Annex 5, TRS No 999World Health Organization (WHO)2016GuidanceAnglais
Labelling Guidance for Controlled Temperature Chain (CTC) Qualification for Vaccine Manufacturers (2020) World Health Organization (WHO)2020GuidanceAnglais
Hepatitis B vaccines: WHO position paper - July 2017World Health Organization (WHO)2017GuidanceArabe, Chinois, Anglais, Français, Russe, Espagnol

EPI-CORE-MENINGITIS

TitreAuteurAnnéeTypeLangue
Meningococcal vaccines: WHO position paperWorld Health Organization (WHO)GuidanceArabe, Chinois, Anglais, Français, Russe, Espagnol
Meningococcal A conjugate vaccine: updated guidanceWorld Health Organization (WHO)2015Journal articleAnglais
Meningitis outbreak response in sub-Saharan AfricaWorld Health Organization (WHO)2014ReportAnglais
Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis BeltWorld Health Organization (WHO)2019GuidanceAnglais
Epidemic meningitis surveillance in the African meningitis beltWorld Health Organization (WHO)2014GuidanceAnglais
Surveillance tools for meningitis sentinel hospital surveillance: field guide to rapidly estimate the hospital catchment population (denominator) and the annual rate of hospitalisationsWorld Health Organization (WHO)2015GuidanceAnglais
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managersWorld Health Organization (WHO)2013GuidanceAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : adaptation guide and facilitators guideWorld Health Organization (WHO)2013GuidanceAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : training module for organizing immunization sessionsWorld Health Organization (WHO)2013TrainingAnglais, Français

OPTIMIZE_CTC

Vous pouvez trouver plus d’informations sur "OPTIMIZE_CTC" dans les rubriques suivantes :

TitreAuteurAnnéeTypeLangue
Controlled temperature chain: Taking advantage of the true heat stability of vaccinesPATH, World Health Organization (WHO)2012Case studyAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managersWorld Health Organization (WHO)2013GuidanceAnglais, Français

Ajouté par: Dan Brigden

Ajouté le: 2015-08-13 13:14:26

Consultations: 4665

Liens

Ajouter une ressource